XHS 📈 SPDR S&P Health Care - Overview
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A5737 • Health
XHS: Hospitals, Medical, Facilities, Laboratories, Insurance, Pharmaceuticals
In seeking to track the performance of the S&P Health Care Services Select Industry Index (the index), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the health care services segment of the S&P Total Market Index (S&P TMI). ‣ Company URL: http://www.spdrs.com ‣ Domicile: United States
Additional Sources for XHS ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
XHS ETF Overview
| Market Cap in USD | 78m |
| Category | Health |
| TER | 0.35% |
| IPO / Inception | 2011-09-28 |
XHS ETF Ratings
| Growth 5y | 27.1% |
| Fundamental | - |
| Dividend | 17.6% |
| Rel. Strength Industry | -96.5 |
| Analysts | - |
| Fair Price Momentum | 82.26 USD |
| Fair Price DCF | - |
XHS Dividends
| Dividend Yield 12m | 0.28% |
| Yield on Cost 5y | 0.35% |
| Annual Growth 5y | -34.91% |
| Payout Consistency | 71.2% |
XHS Growth Ratios
| Growth Correlation 3m | -4.8% |
| Growth Correlation 12m | 75.4% |
| Growth Correlation 5y | 18.4% |
| CAGR 5y | 4.77% |
| CAGR/Mean DD 5y | 0.31 |
| Sharpe Ratio 12m | -0.10 |
| Alpha | -25.52 |
| Beta | 1.04 |
| Volatility | 22.37% |
| Current Volume | 1.4k |
| Average Volume 20d | 2.7k |
What is the price of XHS stocks?
As of December 22, 2024, the stock is trading at USD 90.63 with a total of 1,400 shares traded.
Over the past week, the price has changed by -4.70%, over one month by -3.23%, over three months by -8.39% and over the past year by +0.86%.
As of December 22, 2024, the stock is trading at USD 90.63 with a total of 1,400 shares traded.
Over the past week, the price has changed by -4.70%, over one month by -3.23%, over three months by -8.39% and over the past year by +0.86%.
Is SPDR S&P Health Care a good stock to buy?
Neither. Based on ValueRay Analyses, SPDR S&P Health Care is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.09 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHS as of December 2024 is 82.26. This means that XHS is currently overvalued and has a potential downside of -9.24%.
Neither. Based on ValueRay Analyses, SPDR S&P Health Care is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 27.09 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of XHS as of December 2024 is 82.26. This means that XHS is currently overvalued and has a potential downside of -9.24%.
Is XHS a buy, sell or hold?
SPDR S&P Health Care has no consensus analysts rating.
SPDR S&P Health Care has no consensus analysts rating.
What are the forecast for XHS stock price target?
According to ValueRays Forecast Model, XHS SPDR S&P Health Care will be worth about 91.6 in December 2025. The stock is currently trading at 90.63. This means that the stock has a potential upside of +1.06%.
According to ValueRays Forecast Model, XHS SPDR S&P Health Care will be worth about 91.6 in December 2025. The stock is currently trading at 90.63. This means that the stock has a potential upside of +1.06%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 91.6 | 1.1% |